PT Phapros Tbk (ISX:PEHA) Accounts Payable: Rp82,386 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PEHA PT Phapros Tbk ISX:PEHA
74 GF Score
Price Rp254.00
GF Value Rp383.34
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is PT Phapros Tbk Accounts Payable?

PT Phapros Tbk ISX:PEHA -0.78% 74 Accounts Payable is Rp82,386 Mil as of Mar. 2026. GuruFocus rates ISX:PEHA with a GF Score™ of 74/100 and a GF Value™ of Rp383.34 (Possible Value Trap). The stock has 5 warning signs investors should review.

PT Phapros Tbk's Accounts Payable for the quarter that ended in Mar. 2026 was Rp82,386 Mil.

PT Phapros Tbk's quarterly Accounts Payable declined from Sep. 2025 (Rp82,018 Mil) to Dec. 2025 (Rp33,830 Mil) but then increased from Dec. 2025 (Rp33,830 Mil) to Mar. 2026 (Rp82,386 Mil).

PT Phapros Tbk's annual Accounts Payable declined from Dec. 2023 (Rp73,395 Mil) to Dec. 2024 (Rp49,723 Mil) and declined from Dec. 2024 (Rp49,723 Mil) to Dec. 2025 (Rp33,830 Mil).


PT Phapros Tbk Accounts Payable Related Terms


PT Phapros Tbk Accounts Payable Historical Data

* Premium members only.

The historical data trend for PT Phapros Tbk's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Phapros Tbk Accounts Payable Chart

PT Phapros Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94,260.62 64,578.67 73,394.77 49,723.22 33,830.29

PT Phapros Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94,266.29 73,046.20 82,017.80 33,830.29 82,385.66
ISX:PEHA
74GF Score
PT Phapros Tbk ISX:PEHA
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Phapros Tbk Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of Rp82,386 Mil mean?
PT Phapros Tbk (ISX:PEHA) has a Accounts Payable of Rp82,386 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PT Phapros Tbk and its competitors.
Is PT Phapros Tbk's Accounts Payable too high?
PT Phapros Tbk's current Accounts Payable is Rp82,386 Mil. Overall, PT Phapros Tbk has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's Accounts Payable compare to ZTS and UTHR?
PT Phapros Tbk's Accounts Payable of Rp82,386 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PT Phapros Tbk and its competitors. PT Phapros Tbk's current Accounts Payable is Rp82,386 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp383.34, compared to a current price of Rp254.00 — trading 33.7% below its estimated fair value. The current Accounts Payable is Rp82,386 Mil. PT Phapros Tbk's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current Accounts Payable is Rp82,386 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued. The current stock price of Rp254.00 is trading 33.7% below its estimated GF Value™ of Rp383.34. GuruFocus considers PT Phapros Tbk to be Possible Value Trap.

Key valuation signals for ISX:PEHA:

  • Accounts Payable: Rp82,386 Mil
  • GF Value™: Rp383.34 vs. price of Rp254.00 (33.7% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Phapros Tbk Business Description

Address Jl. Dr. Ide Anak Agung Gde Agung, Menara Rajawali Lt. 17, Kuningan, Jakarta Selatan, Jakarta, IDN, 12950
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
74GF Score

Get the complete analysis for ISX:PEHA

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp254.00
Price
Rp383.34
GF Value